Ped ALL 003 A2G Mtx 5 g/m2

Ped ALL 014abcd A2G cytarabin 75 mg/m2

Ped ALL 029 Interfant-21 Induksjon 1 cytarabin/dauno/pegaspaginase/vinkristin

Ped ALL 030 Interfant-21 Protokoll IB Syklofosfamid enkeltdose

Ped ALL 031 Interfant-21 MARMA del 1, HD metotreksat

Ped ALL 032 Interfant-21 MARMA del 2, HD cytarabin

Ped ALL 049 Vinkristin ALL barn

Ped ALL 055 EsPhALL-2017 Konsolidering blokk 1

Ped ALL 059 EsPhALL 2017 syklofosfamid

Ped ALL 060abc og 061 abcdefg Blinatumomab 5/15 µg/m2/døgn, < 45 KG

Ped ALL 062 IntReALL trippel i.t.

Ped ALL 069ab EsPhALL 2017. Senintensivering (1 og 2) del 1

Ped ALL 070 EsPhALL 2017 EsPhALL 2017 senint. del 2 dag 36-49 cytarabin/syklofosfamid

Ped ALL 081ab A2G pegaspargase i.v./i.m.

Ped ALL 082 A2G daunorubicin/vinkristin, induksjon B

Ped ALL 083 A2G doksorubicin/vinkristin, senintensivering

Ped ALL 084 A2G syklofosfamid, postinduksjon

Ped ALL 087 A2G syklofosfamid/vinkristin, senint. HR

Ped ALL 091ab A2G pegaspargase/vinkristin, senint. HR

Ped ALL 092ab A2G daunorubicin/pegaspargase/vinkristin, uke 3/4, ind. C

Ped ALL 093 A2G/EsPhALL/Interfant trippel i.t.

Ped ALL 098 EsPhALL 2017 pegaspargase iv

Ped ALL 099 EsPhALL 2017 Ind. 1A del 2, daunorubicin/vinkristin dag 15, 22

Ped ALL 100ab-101ab EsPhALL Erwinia-asparaginase (krisantaspase) istedenfor PEG-asparaginase

Ped ALL 126abc og 127abc Blinatumomab 9/28 µg/døgn